cas 1170640-53-5|| where to buy ethyl 3-carbamoyl-2-(4-methyl-1,2,3-thiadiazole-5-amido)-4H,5H,6H,7H-thieno[2,3-c]pyridine-6-carboxylate

Nom du produit:ethyl 3-carbamoyl-2-(4-methyl-1,2,3-thiadiazole-5-amido)-4H,5H,6H,7H-thieno[2,3-c]pyridine-6-carboxylate

IUPAC Name:ethyl 3-carbamoyl-2-(4-methyl-1,2,3-thiadiazole-5-amido)-4H,5H,6H,7H-thieno[2,3-c]pyridine-6-carboxylate

: CAS：1170640-53-5; Formule moléculaire：C15H17N5O4S2; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1170640-53-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1170640-53-5; Formule moléculaire:C15H17N5O4S2; Point de fusion:-; Code SMILES:CCOC(=O)N1CCC2=C(C1)SC(NC(=O)C1=C(C)N=NS1)=C2C(N)=O; Densité:

: Numéro de catalogue:CM920129; Poids moléculaire:395.45; Point d'ébullition:; N° Mdl:; Stockage:

: Thiadiazoles; Thiadiazoles are a subfamily of azoles. Structurally, they are five-membered heterocyclic compounds containing two nitrogen atoms and one sulfur atom, and two double bonds, forming an aromatic ring. Depending on the relative positions of the heteroatoms, there are four possible structures; these forms do not interconvert and are therefore structural isomers rather than tautomers. These compounds themselves are rarely synthesized and have no particular utility, however, compounds that use them as structural motifs are fairly common in pharmacology.

: Thienopyridines; Thienopyridines are similar in structure to quinoline and isoquinoline, and are a class of heterocyclic compounds with important physiological activity and medicinal value. Thienopyridines are a subclass of antiplatelet drugs that prevent platelet aggregation by binding to selected extracellular cysteine residues on the P2Y12 receptor located on the platelet membrane.